Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Banks, Clinical Laboratory Improvement Amendments, College of American Pathologists, Cystic Fibrosis Foundation and The Joint Commission. Why Join Our Team? • Innovation: Be part of a dynamic team at the
-
UC salary scales [https://www.ucop.edu/academic-personnel-programs/compensation/index.html ] set the minimum pay determined by rank and step at appointment. See Table 5. The salary range
-
, Clinical Laboratory Improvement Amendments, College of American Pathologists, Cystic Fibrosis Foundation and The Joint Commission. Why Join Our Team? • Innovation: Be part of a dynamic team at the forefront
-
Compensation Plan. UC Salary information can be found here: https://www.ucop.edu/academic-personnel-programs/compensation/2024-25-academic-salary-scales.html . Application Window Open date: May 17, 2025 Most
-
the Health Sciences Compensation Plan. UC Salary information can be found here: https://www.ucop.edu/academic-personnel-programs/compensation/2024-25-academic-salary-scales.html Application Window Open date
-
https://www.ubjobs.buffalo.edu/postings/54304 Employer University Affiliates Appointment Term Position Type Posting Detail Information Position Summary The UBMD Internal Medicine , Division of Pulmonary
-
https://www.ubjobs.buffalo.edu/postings/54304 Employer University Affiliates Appointment Term Position Type Posting Detail Information Position Summary The UBMD Internal Medicine , Division of Pulmonary
-
the Cystic Fibrosis Therapeutics Development Network Coordinating Center (CF TDNCC) at Seattle Children’s Research Institute, in the Center of Respiratory Biology and Therapeutics. The successful candidate
-
Essential duties and responsibilities include the following. Other duties may be assigned. 1. Be an active participant in the multidisciplinary Cystic Fibrosis Clinic. 2. Ensure that days, evenings, and
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 3 months ago
clinical programs in liver disease associated with cystic fibrosis and in non-alcoholic fatty liver disease, in addition to strengthening our liver transplantation program. The candidate will work closely